全文获取类型
收费全文 | 21626篇 |
免费 | 1652篇 |
国内免费 | 723篇 |
专业分类
耳鼻咽喉 | 42篇 |
儿科学 | 221篇 |
妇产科学 | 152篇 |
基础医学 | 994篇 |
口腔科学 | 152篇 |
临床医学 | 1567篇 |
内科学 | 2666篇 |
皮肤病学 | 286篇 |
神经病学 | 1944篇 |
特种医学 | 215篇 |
外国民族医学 | 1篇 |
外科学 | 881篇 |
综合类 | 2426篇 |
一般理论 | 3篇 |
预防医学 | 1234篇 |
眼科学 | 173篇 |
药学 | 8920篇 |
7篇 | |
中国医学 | 1418篇 |
肿瘤学 | 699篇 |
出版年
2024年 | 68篇 |
2023年 | 341篇 |
2022年 | 510篇 |
2021年 | 731篇 |
2020年 | 740篇 |
2019年 | 777篇 |
2018年 | 788篇 |
2017年 | 861篇 |
2016年 | 772篇 |
2015年 | 755篇 |
2014年 | 1499篇 |
2013年 | 2267篇 |
2012年 | 1362篇 |
2011年 | 1443篇 |
2010年 | 1168篇 |
2009年 | 941篇 |
2008年 | 875篇 |
2007年 | 924篇 |
2006年 | 770篇 |
2005年 | 683篇 |
2004年 | 579篇 |
2003年 | 560篇 |
2002年 | 404篇 |
2001年 | 377篇 |
2000年 | 301篇 |
1999年 | 267篇 |
1998年 | 245篇 |
1997年 | 248篇 |
1996年 | 232篇 |
1995年 | 197篇 |
1994年 | 169篇 |
1993年 | 197篇 |
1992年 | 202篇 |
1991年 | 153篇 |
1990年 | 142篇 |
1989年 | 120篇 |
1988年 | 127篇 |
1987年 | 87篇 |
1986年 | 98篇 |
1985年 | 138篇 |
1984年 | 127篇 |
1983年 | 93篇 |
1982年 | 102篇 |
1981年 | 75篇 |
1980年 | 78篇 |
1979年 | 65篇 |
1978年 | 72篇 |
1977年 | 65篇 |
1976年 | 53篇 |
1975年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
良性前列腺增生(BPH)是老年男性常见的泌尿系统疾病,其发病与前列腺慢性炎症之间存在显著相关。感染因子、尿液返流、代谢综合征、衰老过程和自身免疫应答在内的几种刺激,通过相应分子途径引起前列腺免疫细胞的组织定位和组成成分发生广泛改变,从而导致免疫系统失调,之后引发的组织损伤和缓慢愈合,导致了BPH发生和进展。本文通过总结良性前列腺增生与前列腺慢性炎症的相关性的临床研究结果,前列腺免疫细胞在病理生理机制层面与前两者之间的内在联系,以及抗炎药物对BPH-LUTS的干预作用,以其为BPH-LUTS的药物研发提供参考。 相似文献
2.
Cristiano Colalto 《Drug development research》2020,81(8):950-968
COVID-19 is a novel coronavirus disease with a higher incidence of bilateral pneumonia and pleural effusion. The high pulmonary tropism and contagiousness of the virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), have stimulated new approaches to combat its widespread diffusion. In developing new pharmacological strategies, the chemical characteristic of volatility can add therapeutic value to the hypothetical drug candidate. Volatile molecules are characterized by a high vapor pressure and are consequently easily exhaled by the lungs after ingestion. This feature could be exploited from a pharmacological point of view, reaching the site of action in an uncommon way but allowing for drug delivery. In this way, a hypothetical molecule for COVID-19 should have a balance between its lung exhalation characteristics and both antiviral and anti-inflammatory pharmacological action. Here, the feasibility, advantages, and disadvantages of a therapy based on oral administration of possible volatile drugs for COVID-19 will be discussed. Both aerosolized antiviral therapy and oral intake of volatile molecules are briefly reviewed, and an evaluation of 1,8-cineole is provided in view of a possible clinical use and also for asymptomatic COVID-19. 相似文献
3.
It is hypothesized that persons who use drugs (PWUD) in Vietnam who are also HIV-positive may face additional challenges in psychosocial outcomes, and these challenges may extend to their family members. In this study, we examined depressive symptoms, stigma, social support, and caregiver burden of HIV-positive PWUD and their family members, compared to the outcomes of HIV-negative PWUD and their family members. Baseline, 3-month, and 6-month assessment data were gathered from 83 PWUD and 83 family members recruited from four communes in Phú Th? Province, Vietnam. For PWUD, although we observed a general decline in overall stigma over time for both groups, HIV-positive PWUD consistently reported significantly higher overall stigma for all three periods. Depressive symptoms among family members in both groups declined over time; however, family members of HIV-positive PWUD reported higher depressive symptoms across all three periods. In addition, family members of HIV-positive PWUD reported lower levels of tangible support across all three periods. Caregiver burden among family members of HIV-positive PWUD increased significantly over time, whereas the reported burden among family members of HIV-negative PWUD remained relatively unchanged. The findings highlight the need for future interventions for PWUD and family members, with targeted and culturally specific strategies to focus on the importance of addressing additional stigma experienced by PWUD who are HIV-positive. Such challenges may have direct negative impact on their family members' depressive symptoms, tangible support, and caregiver burden. 相似文献
4.
5.
6.
目的 了解解放军总医院抗震颤麻痹药物的应用情况与用药趋势。方法 采用世界卫生组织(WHO)推荐的以限定日剂量(DDD)为指标的分析方法,对2015-2017年解放军总医院抗震颤麻痹药物的销售金额、用药频度(DDDs)、日均费用(DDC)及排序比(B/A)等进行统计分析。结果 普拉克索、多巴丝肼和恩他卡朋的用药金额始终处于前3位,普拉克索的用药金额逐渐上升,卡比多巴/左旋多巴的用药金额逐渐下降;DDDs排序列前2位的是多巴丝肼和司来吉兰,多巴丝肼的DDDs逐年上升,一直处于第1位;2015-2016年各种抗震颤麻痹药物的DDC较为稳定,2016-2017年各种抗震颤麻痹药物的DDC开始略有下降;除普拉克索和恩他卡朋的B/A始终小于1.00,其他抗震颤麻痹药物的B/A均在1.00以上波动。结论 解放军总医院抗震颤麻痹药物的使用较为合理,其中多巴丝肼、普拉克索和司来吉兰具有很好的市场前景。 相似文献
7.
《Saudi Pharmaceutical Journal》2020,28(10):1243-1252
The novel coronavirus outbreak has reported to be rapidly spreading across the countries and becomes a foremost community health alarm. At present, no vaccine or specific drug is on hand for the treatment of this infectious disease. This review investigates the drugs, which are being evaluated and found to be effective against nCOVID-19 infection. A thorough literature search was performedon the recently published research papers in between January 2020 to May 2020, through various databases like “Science Direct”, “Google Scholar”, “PubMed”,“Medline”, “Web of Science”, and “World Health Organization (WHO)”. We reviewed and documented the information related with the current and future aspects for the management and cure of COVID-19. As of 21st July 2020 a total of 14,562,550 confirmed cases of coronavirus and 607,781 deaths have been reported world-wide. The main clinical feature of COVID-19 ranges from asymptomatic disease to mild lower respiratory tract illness to severe pneumonia, acute lung injury, acute respiratory distress syndrome (ARDS), multiple organ dysfunction, and death. The drugs at present used in COVID-19 patients and ongoing clinical trials focusing on drug repurposing of various therapeutic classes of drug e.g. antiviral, anti-inflammatory and/or immunomodulatory drugs along with adjuvant/supportive care. Many drugs on clinical trials shows effective results on preliminary scale and now used currently in patients. Adjuvant/supportive care therapy are used in patients to get the best results in order to minimize the short and long-term complications. However, further studies and clinical trials are needed on large scale of population to reach any firm conclusion in terms of its efficacy and safety. 相似文献
8.
结核病是由结核分枝杆菌复合群引起的传染性疾病,是全球主要的流行病种之一。利福平是当前最主要的一线抗结核药物,因其长期应用和不规范治疗,利福平耐药逐渐增加,利福喷丁、利福布汀等利福霉素类衍生物在抗结核治疗方面起到了重要作用。基于利福霉素类药物的药理及药动学特性,对该类药物在结核病治疗中进行最优用药选择分析,并对该类药物与其他抗结核药物联用进行综述,旨在为利福霉素类抗结核药物的临床用药提供文献依据。 相似文献
9.
10.